共 47 条
- [41] Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (02) : 194 - 204
- [42] Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials Clinical Research in Cardiology, 2020, 109 : 194 - 204
- [43] Optimal Timing of Percutaneous Coronary Intervention in Patients With Non-ST-Segment Elevation Myocardial Infarction Complicated by Acute Decompensated Heart Failure (from the Korea Acute Myocardial Infarction Registry-National Institutes of Health [KAMIR-NIH]) AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (11): : 1285 - 1292
- [44] β-Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In-Hospital and 12-Month Outcome: Results From the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2) JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (12):
- [45] Beta-blocker Therapy in Acute Coronary Syndromes: a Time-Trend Interpretation of Evolving Clinical Benefits: Editorial to: "The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-up Study" by JC Nicolau et al. CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (05) : 409 - 411
- [46] Beta-blocker Therapy in Acute Coronary Syndromes: a Time-Trend Interpretation of Evolving Clinical BenefitsEditorial to: “The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-up Study” by J.C. Nicolau et al. Cardiovascular Drugs and Therapy, 2018, 32 : 409 - 411
- [47] Clinical Efficacy and Safety of Early Intravenous Administration of Beta-Blockers in Patients Suffering from Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure Undergoing Primary Percutaneous Coronary Intervention: A Study-Level Meta-Analysis of Randomized Clinical Trials CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (04) : 833 - 846